Related Experiment Video
Updated: Jun 10, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Bilateral panuveitis following intravesical BCG immunotherapy for bladder carcinoma
Gurmit S Uppal1, Anish N Shah, Charalambos M Tossounis
1Moorfields Eye Hospital, London, UK.
Purpose:
To report a case of bilateral panuveitis following local treatment with Bacille Calmette-Guérin (BCG) immunotherapy for superficial bladder carcinoma.
Design:
Case report and literature review.
Methods:
A 70-year-old female presented with severe bilateral anterior chamber inflammation 5 days after intravesical BCG instillation. Despite topical steroids and mydriatics, inflammation worsened and bilateral optic nerve swelling developed.
Results:
Oral corticosteroids settled the ocular inflammation, and optic nerve function recovered. A trial of steroid cessation caused rebound uveitis, so she remains on maintenance doses of oral corticosteroid.
Conclusions:
Ocular inflammations following BCG therapy for bladder cancer are rare, and little is known about the management of such cases. This is the first report of bilateral panuveitis with optic nerve edema following such treatment.
Related Concept Videos
Imaging Studies VI: Voiding Cystourethrography and Cystography
Kidney Transplant II: Surgical Procedure
Tumor Immunotherapy